Ceres Brain Therapeutics

This early-stage trial tested the safety and tolerability of a new nasal spray called CBT101 in 48 healthy men. Participants received either a single dose or multiple doses over several days. The study did not aim to treat any disease, but to gather initial safety data before tes…